Intravenous Dexmedetomidine For The Quaity Of Emergence From General Anesthesia

Postoperative Recovery Clinical Trial

Official title: Intravenous Dexmedetomidine For The Quaity Of Emergence From General Anesthesia: A Dose-Finding Study

Status Completed

Clinical Trial Summary

In a prospective randomized clinical trial involving adult patients undergoing elective surgery under general anesthesia, the investigators will enroll 216 patients, and evaluate 3 doses of prophylactic dexmedetomidine as a means to reduce postoperative shivering and quality of emergence from anesthesia versus placebo.

Clinical Trial Description

Patients undergoing surgery under general anesthesia may experience several complications during the postoperative period. Shivering has been reported to occur in up to 65% of patients recovering from general anesthesia, and has been shown to cause detrimental effects to the patient. Previous studies have shown that dexmedetomidine 1µg/kg at the end of surgery significantly reduces the incidence of postoperative shivering and improves quality of emergence from anesthesia. However, this beneficial effect of dexmedetomidine is at the expense of prolonged time to extubation and awakening. The aim of this study is to find the optimal dose of dexmedetomidine that would be beneficial without delaying recovery from general anesthesia. ;

Related Conditions & MeSH terms

• Anesthesia Emergence
• Anesthesia Recovery
• Postoperative Recovery
• Shivering

• NCT number: NCT02141412
• Study type: Interventional
• Source: American University of Beirut Medical Center
• Status: Completed
• Phase: Phase 4
• Start date: September 2009
• Completion date: September 2015